CirChem AB (SE:CIRCHE)
:CIRCHE
Want to see SE:CIRCHE full AI Analyst Report?
Top Page
CirChem AB
(CIRCHE)
Select Model
Select Model
Rating:43Neutral
Price Target:
kr0.97
▲(13.53% Upside)
Action:Reiterated
Date:05/14/26
The score is driven primarily by weak financial performance (sharp TTM revenue decline, deeply negative margins, and significant cash burn) despite moderate balance sheet leverage. Technical signals also lean bearish with the stock below major moving averages and negative MACD. Valuation provides limited support because earnings are negative and there is no dividend yield.
Positive Factors
Recurring revenue model
CirChem's core business collects fees for solvent recycling plus sales of purified solvents. That creates dual, complementary revenue streams tied to industrial input needs and service contracts, supporting predictable demand and repeat customer relationships over multiple quarters.
Negative Factors
Sharp revenue deterioration
A roughly 67% TTM revenue drop reflects severe demand or contract losses and erodes the scale needed for fixed-cost absorption. Over the next 2–6 months, sustaining operations and rebuilding customer volumes will be harder, making recovery dependent on winning back contracts or new stable offtake agreements.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring revenue model
CirChem's core business collects fees for solvent recycling plus sales of purified solvents. That creates dual, complementary revenue streams tied to industrial input needs and service contracts, supporting predictable demand and repeat customer relationships over multiple quarters.
Read all positive factors
CirChem AB (CIRCHE) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr38.36M
Dividend YieldN/A
Average Volume (3M)64.80K
Price to Earnings (P/E)―
Beta (1Y)-0.12
Revenue Growth-66.96%
EPS Growth-1530.58%
CountrySE
Employees13
SectorIndustrials
Sector Strength72
IndustryWaste Management
Share Statistics
EPS (TTM)-0.40
Shares Outstanding40,205,837
10 Day Avg. Volume121,416
30 Day Avg. Volume64,798
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.74
Price to Sales (P/S)3.28
P/FCF Ratio-1.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)kr40.60M
CirChem AB Business Overview & Revenue Model
Company Description
CirChem AB (publ) engages in recycling of used solvents in Sweden. It collects and purify used industrial solvents for reuse; and produces other chemical products, such as washer fluid and rubbing alcohol. CirChem AB (publ)was founded in 2013 and ...
How the Company Makes Money
CirChem AB’s revenue model is based on providing solvent recycling services and selling recovered solvents back into the market. Key revenue streams would typically include (1) fees charged to industrial customers for collecting, handling, and pro...
CirChem AB Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
58
Neutral
Cash Flow
20
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.50M | 9.96M | 20.66M | 5.75M | 590.62K | 85.55K |
| Gross Profit | -4.69M | -11.24M | 19.53M | 3.04M | 2.92M | 2.62M |
| EBITDA | -13.55M | -10.12M | 374.00K | -15.52M | -19.87M | -16.74M |
| Net Income | -15.50M | -12.05M | -1.07M | -17.14M | -25.50M | -19.48M |
Balance Sheet | ||||||
| Total Assets | 64.18M | 69.47M | 61.18M | 59.11M | 50.30M | 52.14M |
| Cash, Cash Equivalents and Short-Term Investments | 6.77M | 13.65M | 11.93M | 16.58M | 9.78M | 14.57M |
| Total Debt | 13.31M | 12.90M | 8.92M | 8.92M | 1.75M | 2.00M |
| Total Liabilities | 24.69M | 25.14M | 15.49M | 24.00M | 25.17M | 25.77M |
| Stockholders Equity | 39.49M | 44.33M | 45.68M | 35.10M | 25.13M | 26.37M |
Cash Flow | ||||||
| Free Cash Flow | -22.68M | -20.57M | -12.85M | -27.48M | -25.27M | -5.47M |
| Operating Cash Flow | -15.54M | -13.70M | -6.38M | -26.68M | -21.49M | -2.78M |
| Investing Cash Flow | -7.15M | -6.88M | -6.47M | -798.49K | -3.78M | -2.69M |
| Financing Cash Flow | 21.13M | 22.29M | 8.20M | 34.29M | 20.48M | -2.04M |
CirChem AB Technical Analysis
Negative
0.85
Price Trends
1.04
Negative
1.03
Negative
1.28
Negative
Market Momentum
-0.02
Positive
44.77
Neutral
5.83
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CIRCHE, the sentiment is Negative. The current price of 0.85 is below the 20-day moving average (MA) of 1.00, below the 50-day MA of 1.04, and below the 200-day MA of 1.28, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 44.77 is Neutral, neither overbought nor oversold. The STOCH value of 5.83 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:CIRCHE.
CirChem AB Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | kr132.33M | -5.59 | -94.54% | ― | 46.99% | 16.83% | |
51 Neutral | kr185.37M | 42.87 | ― | ― | 5.49% | -37.17% | |
47 Neutral | kr102.78M | -13.28 | -17.60% | ― | 65.80% | 73.02% | |
46 Neutral | kr207.10M | -0.75 | -20.69% | ― | -81.53% | -634.82% | |
46 Neutral | kr92.15M | -7.45 | -14.54% | ― | -20.87% | ― | |
43 Neutral | kr38.36M | -2.14 | -25.32% | ― | -66.96% | -1530.58% |
* Industrials Sector Average
SE:CIRCHE
CirChem AB
0.95
-1.39
-59.23%
SE:SES
Scandinavian Enviro Systems AB
0.19
-0.60
-76.11%
SE:AXOLOT
Axolot Solutions Holding AB
0.32
-0.08
-19.40%
SE:BIOEX
Bioextrax AB
2.78
-0.27
-8.70%
SE:SAXG
Saxlund Group AB
12.80
3.10
31.96%
SE:NOTEK
Norditek Group AB
13.50
-1.00
-6.90%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.